BG
SGHT icon

Bellevue Group’s Sight Sciences SGHT Stock Holding History

Bellevue Group’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-286,284
Closed -$2.37M – 163
2023
Q2 		$2.37M Hold
286,284
– – 0.03% 111
2023
Q1 		$2.5M Sell
286,284
-8,322
-3% -$92.4K 0.04% 114
2022
Q4 		$3.6M Hold
294,606
– – 0.05% 118
2022
Q3 		$1.87M Hold
294,606
– – 0.03% 124
2022
Q2 		$2.65M Sell
294,606
-5,394
-2% -$47.5K 0.04% 121
2022
Q1 		$3.47M Hold
300,000
– – 0.04% 126
2021
Q4 		$5.27M Hold
300,000
– – 0.05% 124
2021
Q3 		$6.81M Buy
+300,000
New +$9.86M 0.07% 126

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group's SGHT Position: Q3 2023 in Review

Bellevue Group sold out of Sight Sciences (SGHT) in Q3 2023, closing a stake of 286,284 shares — an estimated $2.37M sold.

Bellevue Group first reported a position in SGHT in Q3 2021 and held it in 8 quarters. The position peaked at $6.81M in Q3 2021. 65 funds tracked by Wall St. Rank hold SGHT as of Q3 2023.

  • Bellevue Group reported no remaining Sight Sciences position as of Q3 2023 after selling out during the quarter.
  • Bellevue Group sold 286,284 Sight Sciences shares in Q3 2023, an estimated $2.37M.
  • Bellevue Group first reported a position in Sight Sciences in Q3 2021 and held it in 8 quarters.
  • Bellevue Group's Sight Sciences position peaked at $6.81M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2023.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.